bullish
Innovent Biologics IPO Valuation: Surprisingly Grounded in Reality
706 Views15 Oct 2018 19:25
Innovent Biologics Inc (1641475D HK) launched its Hong Kong IPO today. The mid-point of Innovent's IPO price range of HK$12.50-14.00 per share...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- WuXi AppTech IPO Trading Update: What’s up with the Poor Cash Conversion?20 Nov 2018
- WuXi AppTech IPO Preview: Pharmed Out19 Nov 2018
- Innovent Biologics IPO First-Day: Take Money off the Table31 Oct 2018
- Innovent Biologics IPO Preview: Limited Upside on China's PD-1 Drug Market Compared to BeiGene02 Oct 2018
- BeiGene (6160 HK): On a Stronger Post-Listing Footing than Ascletis13 Aug 2018
- BeiGene IPO Preview: Lucrative Lifesavers31 Jul 2018
x